EL-ASSAL, M. I.; SAMUEL, D. OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS. International Journal of Pharmacy and Pharmaceutical Sciences, [S. l.], v. 14, n. 1, p. 17–27, 2022. DOI: 10.22159/ijpps.2022v14i1.43145. Disponível em: https://innovareacademics.in/journals/index.php/ijpps/article/view/43145. Acesso em: 1 feb. 2023.